According to Reuters GSK is set to slash 850 jobs in R&D in both the UK and the US.
You can view the article here.
As John Murphy, analyst at Goldman Sachs notes, "R&D is no longer the sacred cow it was in the past."
Subscribe to:
Post Comments (Atom)
.jpg)
No comments:
Post a Comment